Covid-19 vaccines
COVID-19, Covid-19 vaccines, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses
Comprehensive Overview of the I-RECOVER Post-Vaccine Treatment Protocol
Reference: Kory, P., & Marik, P. (2024). I-RECOVER: Post-vaccine treatment protocol. Summary: The I-RECOVER Post-Vaccine Treatment Protocol offers a detailed approach for managing symptoms associated with COVID-19 vaccination injuries. It categorises therapies into first, second, and third-line options, focusing on restoring immune regulation and addressing various clinical manifestations. Key first-line therapies include intermittent fasting, ivermectin,
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
COVID-19 Vaccine Safety Signals: A Global Analysis
Reference: Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., … & Hviid, A. (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. https://doi.org/10.1016/j.vaccine.2024.01.100 Summary: This study evaluates the risk of adverse events following COVID-19 vaccination across
COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses
Differential Increases in Excess Mortality in German Federal States During the COVID-19 Pandemic
Reference: Kuhbandner, C., & Reitzner, M. (2024). Differential increases in excess mortality in the German federal states during the COVID-19 pandemic. Preprint. https://doi.org/10.13140/RG.2.2.13098.18880 Summary: This study examines excess mortality across Germany’s sixteen federal states during the COVID-19 pandemic from April 2020 to March 2023. It utilises statistical methods to assess the observed versus expected deaths,
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
COVID-19 Vaccines and Adverse Events: Insights from a Global Study
Reference: Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., Kwong, J.C., Macartney, K., Naus, M., Grange, Z., Escolano, S., Sepulveda, G., Shetty, A., Pillsbury, A., Sullivan, C., Naveed, Z., Janjua, N.Z., Giglio, N., Perälä, J., Nasreen, S., Gidding, H., Hovi, P., Vo, T., Cui, F., Deng, L., Cullen, L., Artama, M.,
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses
Critical Review of COVID-19 mRNA Vaccines: Safety and Efficacy Concerns
Reference: Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 mRNA vaccines: Lessons learned from the registrational trials and global vaccination campaign. Cureus, 16(1), e52876. https://doi.org/10.7759/cureus.52876 Summary: The article critically examines the safety and efficacy of COVID-19 mRNA vaccines, highlighting significant concerns regarding trial methodologies
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
Safety Concerns in COVID-19 Vaccines: Off-Target Proteins and Immune Responses
Reference: Wiseman, D., Gutschi, L. M., Speicher, D. J., Rose, J., & McKernan, K. (2023). Ribosomal frameshifting and misreading of mRNA in COVID-19 vaccines produces “off-target” proteins and immune responses eliciting safety concerns: Comment on UK study by Mulroney et al. Nature. http://doi.org/10.1038/s41586-023-06800-3 Summary: The article discusses a study by Mulroney et al., which reveals